Crosstalk between MiRNAs/lncRNAs and PI3K/AKT signaling pathway in diabetes mellitus: Mechanistic and therapeutic perspectives

被引:9
|
作者
Aghaei-Zarch, Seyed Mohsen [1 ]
机构
[1] Shahid Beheshti Univ Med Sci, Sch Med, Dept Med Genet, Tehran, Iran
来源
NON-CODING RNA RESEARCH | 2024年 / 9卷 / 02期
关键词
Diabetes mellitus; PI3K/AKT; miRNA; lncRNA; PROMOTES INSULIN-RESISTANCE; ENDOTHELIAL-CELL; MESENCHYMAL TRANSITION; GLUCOSE-METABOLISM; OXIDATIVE STRESS; RAT MODEL; RETINOPATHY; RNA; PROLIFERATION; NEPHROPATHY;
D O I
10.1016/j.ncrna.2024.01.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetes as a fastest growing diseases worldwide is characterized by elevated blood glucose levels. There's an enormous financial burden associated with this endocrine disorder, with unequal access to health care between developed and developing countries. PI3Ks (phosphoinositide 3-kinases) have been demonstrated to be crucial for glucose homeostasis, and malfunctioning of these molecules can contribute to an increase in glucose serum levels, the main pathophysiological feature of diabetes. Additionally, recent evidence suggests that miRNAs and lncRNAs are reciprocally interacting with this signaling pathway. It is therefore evident that abnormal regulation of miRNAs/lncRNAs in the lncRNAs/miRNAs/PI3K/AKT axis is related to clinicopathological characteristics and plays a crucial role in the regulation of biological processes. It has therefore been attempted in this review to describe the interaction between PI3K/AKT signaling pathway and various miRNAs/lncRNAs and their importance in DM biology. We also presented the clinical applications of PI3K/AKT-related ncRNAs/herbal medicine in patients with DM.
引用
收藏
页码:486 / 507
页数:22
相关论文
共 50 条
  • [41] AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV
    Bhatt, Aadra P.
    Damania, Blossom
    FRONTIERS IN IMMUNOLOGY, 2013, 3
  • [42] Role of PI3K/AKT signaling pathway during capacitation
    Lee, Woo-Jin
    Jo, Jae-Hwan
    Uwamahoro, Claudine
    Jang, Seung-Ik
    Jung, Eun-Ju
    Bae, Jeong-Won
    Moon, Joonho
    Kim, Dae-Hyun
    Yi, Jun Koo
    Ha, Jae Jung
    Oh, Dong Yep
    Kwon, Woo-Sung
    THERIOGENOLOGY, 2025, 235 : 94 - 102
  • [43] Upregulation of MMPs in placentas of patients with gestational diabetes mellitus: Involvement of the PI3K/Akt pathway
    Zhang, Yanan
    Liu, Yufen
    Shi, Yanyan
    Bai, Chunyu
    Wang, Ting
    Ruan, Fang
    Hu, Chuanbing
    HELIYON, 2024, 10 (12)
  • [44] The PI3K/AKT pathway in obesity and type 2 diabetes
    Huang, Xingjun
    Liu, Guihua
    Guo, Jiao
    Su, Zhengquan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2018, 14 (11): : 1483 - 1496
  • [45] Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance
    Ediriweera, Meran Keshawa
    Tennekoon, Kamani Hemamala
    Samarakoon, Sameera Ranganath
    SEMINARS IN CANCER BIOLOGY, 2019, 59 : 147 - 160
  • [46] Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer
    Ebrahimi, Safieh
    Hosseini, Mina
    Shahidsales, Soodabeh
    Maftouh, Mina
    Ferns, Gordon A.
    Ghayour-Mobarhan, Majid
    Hassanian, Seyed Mahdi
    Avan, Amir
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (13) : 1321 - 1331
  • [47] PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies-New Therapeutic Possibilities
    Wiese, Wojciech
    Barczuk, Julia
    Racinska, Olga
    Siwecka, Natalia
    Rozpedek-Kaminska, Wioletta
    Slupianek, Artur
    Sierpinski, Radoslaw
    Majsterek, Ireneusz
    CANCERS, 2023, 15 (21)
  • [48] Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
    Yu, Le
    Wei, Jessica
    Liu, Pengda
    SEMINARS IN CANCER BIOLOGY, 2022, 85 : 69 - 94
  • [49] PI3K/Akt signaling in osteosarcoma
    Zhang, Jian
    Yu, Xiao-Hua
    Yan, Yi-Guo
    Wang, Cheng
    Wang, Wen-Jun
    CLINICA CHIMICA ACTA, 2015, 444 : 182 - 192
  • [50] Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy
    Yothaisong, Supak
    Dokduang, Hasaya
    Techasen, Anchalee
    Namwat, Nisana
    Yongvanit, Puangrat
    Bhudhisawasdi, Vajarabhongsa
    Puapairoj, Anucha
    Riggins, Gregory J.
    Loilome, Watcharin
    TUMOR BIOLOGY, 2013, 34 (06) : 3637 - 3648